Aenitis
VerifiedDeveloping a cell treatment device. Learn more
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$528—792k (Dealroom.co estimates Oct 2014.)
Company register number 803512458
Paris Île-de-France (HQ)
- hard tech
- biotechnology
- horizon europe
- eit ecosystem
- observatoire deeptech
- eit health
- biotech, medtech and e-health
- seal of excellence ec
- eicfund
- headstart (eit health)
- immune system
- european health catapult (eit health)
- tissue engineering
- investor network (eit health)
- headstart 2019 (eit health)
- molecular biology
- investor network 2019 (eit health)
- stem cells
- radiation
- european health catapult 2018 (eit health)
| EUR | 2020 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
N/A | Early VC | ||
| Total Funding | 000k | ||
Related Content
Recent News about Aenitis
EditMore about Aenitis
EditDeveloper of a medical device intended to offer assistance for cell therapy preparations. The company's devices focus on cell therapy units and blood banks' challenges by developing bioprocessing medical devices dedicated to cell therapy manufacturing issues including cell sorting, cell washing and cell isolation, enabling the healthcare industry to get acoustic preparation support for cell therapies.
Keywords: Pharmaceuticals and Biotechnology, Cell Isolation, Cell Sorting, Cell Therapy, Cell Washing, Medical Device Firm, Medical Equipment.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.